Trial intelligence / Profile preview

Standard vs High Dose Oxytocin for Postpartum Hemorrhage in High Risk C-Section

NCT06560099Not yet recruiting

Sponsor
Ain Shams University
Start
Aug 2024
Primary completion
Apr 2025
Modality
Peptides
01

Overview

Randomised trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Ain Shams University. Primary endpoint: Blood Loss. Planned start Aug 2024; status: not yet recruiting.

02

Drugs

oxytocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT06560099.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06560099.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call